Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
446.00    1.00 (0.22%)
Bid:
446.00
Ask:
447.00
Spread: 1.00 (0.224%)
Market Cap: £659.65m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

31 Jul 2012 07:00

RNS Number : 8643I
Creston PLC
31 July 2012
 



31 July 2012

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2012 to date.

 

Trading update

 

For the three months to 30 June 2012 (the 'Period'), the Group reported revenue growth of just over 1 per cent compared to the same period last year. As anticipated, the decline in retained revenues reported in the final quarter of the last financial year has impacted the first three months of trading in the current financial year, and as a consequence, like-for-like1 revenue for the first quarter was down just under 7 per cent, compared to the same period in 2011.

 

Communications

The Group's largest division, Communications, has performed broadly in line with the prior year in terms of first quarter revenue. TMW, the Nelson Bostock Group and The Real Adventure have all delivered growth in revenue with some significant new business wins. This new business includes: TMW being appointed to work on Sony Mobile's global social media strategy and winning projects from new clients such as BBC Good Food; the Nelson Bostock Group being hired by Cartoon Network; and The Real Adventure winning its first global account for Danone Baby Nutrition, helping the team to develop pioneering CRM strategies across Europe and beyond. EMO experienced a decline in first quarter revenue compared to the same prior year period due to the decline in retained revenues reported at the end of the last financial year, however, it too is experiencing an uplift in new business opportunities. The division overall, with its good new business performance and pipeline, and a full year effect of last year's cost reductions, is positioned for another year of growth.

 

Health

The stabilisation of the healthcare sector has continued and the division saw a small increase in like-for-like revenue during the first three months compared to the prior year period. The division is experiencing an increase in new business opportunities, winning more work from new and existing clients and while structural reform remains ongoing in the sector, the Group believes it is well placed to benefit from the resulting opportunities.

 

Insight

As previously reported ICM's performance in the last financial year has, as expected, continued to impact trading during the Period. Significant cost reduction actions were undertaken at the end of the last financial year and management will continue to review the business closely to ensure costs remain aligned to performance as revenue increases again. The wider division's focus on developing further expertise in new research technologies and digital platforms is creating good new business opportunities, and our healthcare focussed start-up company has added three new clients since the start of the new financial year.

 

Outlook

While on a like-for-like basis the Group has had a slower start to the new financial year, primarily as a result of the previously reported lower retained revenues at the end of the last financial year, there have been encouraging new business wins and opportunities across the Group.

 

The Board is pleased with the performance of its recent acquisition The Corkery Group and expects a positive impact from new client wins. However, we naturally remain cautious given the macro environment.

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Don Elgie, Group Chief Executive

Barrie Brien, COO/CFO

M:Communications

+44 (0)20 7920 2339

Elly Williamson

 

About Creston plc

Creston plc (LSE: CRE) is a marketing services company focused on insight-led communications. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to truly understand, influence and inspire consumers and it's that insight-led intelligence that drives our creativity. www.creston.com


1 Excluding the results from any acquisitions made during the current year, like-for-like compares current year performance to the prior year, adjusting the current year to only include the results of prior year acquisitions for the commensurate period of ownership

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAAXEDSNAEAF
Date   Source Headline
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
26th May 20262:53 pmRNS$50 million Share Buyback Programme
20th May 20267:00 amRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSResult of AGM
13th May 20267:00 amRNSTrading Update for Q1 2026
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSNotice of Q1 2026 Trading Update
28th Apr 20267:00 amRNSDirectorate change
28th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20264:54 pmRNSDirector/PDMR Shareholding
10th Apr 20264:26 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20265:56 pmRNSNotice of AGM
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSHolding(s) in Company
30th Mar 20265:27 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
30th Mar 20265:26 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirectorate change
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20263:06 pmRNSDirectorate change
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSPDMR Notification
9th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.